ST椰島(600238.SH):財務總監高曉光辭職 符惠玲補缺
格隆匯 9 月 16日丨ST椰島(600238.SH)公佈,董事會近日收到財務總監高曉光遞交的辭職報告。因個人原因,高曉光申請辭去財務總監職務,辭職後不再擔任公司任何職務,辭職報告自送達公司董事會之日起生效。
根據公司經營管理需要,經公司董事長兼總經理馮彪提名,並經董事會提名委員會審核通過,公司於2020年9月16日召開第七屆董事會第五十四次會議,審議通過了《關於聘任副總經理的議案》及《關於聘任財務總監的議案》,同意聘任齊苗苗為公司副總經理,聘任符惠玲為公司財務總監,任期與第七屆董事會一致。公司獨立董事對齊苗苗、符惠玲的任職資格進行了審核,並發表了同意的獨立意見。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.